Trial Profile

A phase 2 trial of PDS0101B in patients with HPV-related head and neck cancer

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 11 Feb 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs PDS 0101 (Primary)
Indications Head and neck cancer; Human papillomavirus infections
Focus Therapeutic Use
Sponsors PDS Biotechnology Corporation

Most Recent Events

11 Feb 2016 New trial record
09 Feb 2016 According to PDS Biotechnology media release, this trial is expected to initiate in 2016 and 2017.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com